Active: Epilepsia Clear all

GWAS 2022-03-17

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.

Campbell C, McCormack M et al.

Epilepsia

Objective: Levetiracetam (LEV) is an effective antiseizure medicine, but 10%-20% of people treated w...

Response to levetiracetam (behavioral disorder)

1069

Participants

N/A

Studies

Details PubMed

GWAS 2022-02-16

Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti-seizure medications.

Mullan KA, Anderson A et al.

Epilepsia

Objective: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous ...

Aromatic antiseizure medication-induced Stevens-Johnson syndrome or toxic epidermal necrolysis

197

Participants

N/A

Studies

Details PubMed

GWAS 2021-04-29

Genome-wide association study of epilepsy in a Japanese population identified an associated region at chromosome 12q24.

Suzuki T, Koike Y et al.

Epilepsia

Objective: Although a number of genes responsible for epilepsy have been identified through Mendelia...

Epilepsy

9793

Participants

N/A

Studies

Details PubMed

GWAS 2018-07-16

Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.

Schoeler NE, Leu C et al.

Epilepsia

Objective: With the exception of specific metabolic disorders, predictors of response to ketogenic d...

Response to ketogenic dietary therapies in epilepsy

235

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.

Campbell C, McCormack M et al.

Epilepsia

Response to levetiracetam (behavioral disorder)

2022-03-17

Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti-seizure medications.

Mullan KA, Anderson A et al.

Epilepsia

Aromatic antiseizure medication-induced Stevens-Johnson syndrome or toxic epidermal necrolysis

2022-02-16

Genome-wide association study of epilepsy in a Japanese population identified an associated region at chromosome 12q24.

Suzuki T, Koike Y et al.

Epilepsia

Epilepsy

2021-04-29

Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.

Schoeler NE, Leu C et al.

Epilepsia

Response to ketogenic dietary therapies in epilepsy

2018-07-16